Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)
- PMID: 20459608
- PMCID: PMC2874789
- DOI: 10.1186/1471-2296-11-33
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)
Abstract
Background: There is little available data regarding the epidemiology of herpes zoster (HZ) in Spain. This study's main goal was to estimate the annual incidence of HZ in the Autonomous Community of Valencia.
Methods: From December 1st 2006 to December 1st 2007, a prospective study was carried out in 24 primary health care centres that together provide care for a population of 36,030 persons aged >14 years. We included all adult patients with a clinical diagnosis of HZ who were seen at these centres during the one-year study period. Demographic (i.e., age, gender, and area of residence) and clinical data were also collected from these patients.
Results: A total of 146 cases of HZ were identified during the study period. The annual incidence of HZ was 4.1/1,000 individuals >14 years of age (95% confidence interval [CI]: 3.4-4.7). Cases of HZ were predominantly unilateral and most commonly affected women and people living in rural areas. The most frequently reported symptoms were pain, dysesthesia and itching. A total of 46% of patients also had underlying illnesses (e.g., chronic diseases and/or malignancy) and 24% of patients experienced complications, which were mostly ocular in nature. A total of 91% of patients were treated with antiviral drugs. The median time from symptoms onset to diagnosis was 6.3 days (range: 2.0-8.3).
Conclusions: HZ is a common illness in our region (especially in the older population) that causes a significant clinical burden on primary care providers.
Similar articles
-
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.BMC Infect Dis. 2011 Nov 1;11:302. doi: 10.1186/1471-2334-11-302. BMC Infect Dis. 2011. PMID: 22044665 Free PMC article.
-
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7. Hum Vaccin Immunother. 2014. PMID: 24805130 Free PMC article.
-
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).BMC Infect Dis. 2013 Oct 5;13:463. doi: 10.1186/1471-2334-13-463. BMC Infect Dis. 2013. PMID: 24094135 Free PMC article.
-
Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain.Public Health. 2019 Feb;167:136-146. doi: 10.1016/j.puhe.2018.10.015. Epub 2019 Jan 18. Public Health. 2019. PMID: 30660981
-
Herpes zoster: diagnostic, therapeutic, and preventive approaches.Postgrad Med. 2013 Sep;125(5):78-91. doi: 10.3810/pgm.2013.09.2703. Postgrad Med. 2013. PMID: 24113666 Review.
Cited by
-
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.BMC Infect Dis. 2011 Nov 1;11:302. doi: 10.1186/1471-2334-11-302. BMC Infect Dis. 2011. PMID: 22044665 Free PMC article.
-
Balanitis is a risk factor for herpes zoster.Eur J Clin Microbiol Infect Dis. 2015 May;34(5):985-90. doi: 10.1007/s10096-015-2314-0. Epub 2015 Jan 18. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25596845
-
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.BMC Infect Dis. 2014 Dec 6;14:637. doi: 10.1186/s12879-014-0637-6. BMC Infect Dis. 2014. PMID: 25479617 Free PMC article.
-
Herpes zoster and postherpetic neuralgia in Catalonia (Spain).Hum Vaccin Immunother. 2015;11(1):178-84. doi: 10.4161/hv.34421. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483532 Free PMC article.
-
Similar herpes zoster incidence across Europe: results from a systematic literature review.BMC Infect Dis. 2013 Apr 10;13:170. doi: 10.1186/1471-2334-13-170. BMC Infect Dis. 2013. PMID: 23574765 Free PMC article.
References
-
- Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360:678–682. - PubMed
-
- Ly Pen D, Manzano Espinosa L. Neuralgia postherpética: incidencia, prevención y tratamiento. Rev Clin Esp. 2007;207:23–28.
-
- Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32:1481–1486. - PubMed
-
- Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardmand KD, Williams HM, Hongyuan Zhang J, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan ISF, Wang WWB, Annunziato PW, Silber JL. for the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–2284. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical